Austria

Austria

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.03 (0.51 - 1.89) 2015 Modelled WHO
1.23 (0.81 - 1.86) 2013 Modelled Schweitzer et al, 2015
0.76 (0.61 - 0.91) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.82 (0.67 - 0.96) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.66 - 0.97) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.69 - 0.99) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.70 - 1.02) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.02) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.02) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.74 - 1.03) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.75 - 1.04) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.75 - 1.04) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.76 - 1.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.77 - 1.07) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.77 - 1.09) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.78 - 1.11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.78 - 1.13) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.13) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.81 - 1.14) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.16) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.82 - 1.19) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.83 - 1.19) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.83 - 1.21) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.84 - 1.21) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.84 - 1.22) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.84 - 1.21) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.85 - 1.21) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.85 - 1.22) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.85 - 1.23) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.85 - 1.24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.66 - 0.97) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.32 (0.15 - 0.62) 2015 Modelled WHO
0.06 (0.04 - 0.08) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.09 (0.06 - 0.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.13) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.12) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.06 - 0.14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.07 - 0.17) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.07 - 0.17) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.08 - 0.17) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.08 - 0.17) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.08 - 0.17) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.08 - 0.18) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.10 - 0.21) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.13 - 0.28) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.17 - 0.38) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.35 (0.21 - 0.48) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.25 - 0.58) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.30 - 0.66) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.35 - 0.75) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.40 - 0.84) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.43 - 0.92) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.45 - 0.96) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.45 - 0.97) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.45 - 0.97) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.46 - 0.97) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.46 - 0.96) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.45 - 0.97) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.10 - 0.23) 2020 Modelled WHO
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
2.6 2017 Survey/reported EMCDDA
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
67,527 (54,458 - 80,815) 2019 Modelled IHME, GBD 2019 (accessed 2020)
69,169 (55,497 - 82,570) 2019 Modelled IHME, GBD 2019 (accessed 2022)
68,802 (56,298 - 80,975) 2018 Modelled IHME, GBD 2019 (accessed 2022)
68,700 (55,609 - 81,418) 2017 Modelled IHME, GBD 2019 (accessed 2022)
70,019 (57,286 - 81,800) 2016 Modelled IHME, GBD 2019 (accessed 2022)
71,252 (57,486 - 83,675) 2015 Modelled IHME, GBD 2019 (accessed 2022)
71,120 (58,082 - 83,145) 2014 Modelled IHME, GBD 2019 (accessed 2022)
71,094 (58,292 - 82,525) 2013 Modelled IHME, GBD 2019 (accessed 2022)
71,206 (59,044 - 82,413) 2012 Modelled IHME, GBD 2019 (accessed 2022)
71,439 (59,425 - 82,537) 2011 Modelled IHME, GBD 2019 (accessed 2022)
71,748 (59,653 - 82,986) 2010 Modelled IHME, GBD 2019 (accessed 2022)
72,297 (60,302 - 83,346) 2009 Modelled IHME, GBD 2019 (accessed 2022)
73,120 (61,001 - 84,436) 2008 Modelled IHME, GBD 2019 (accessed 2022)
73,973 (61,082 - 85,511) 2007 Modelled IHME, GBD 2019 (accessed 2022)
74,652 (61,176 - 86,739) 2006 Modelled IHME, GBD 2019 (accessed 2022)
74,941 (61,240 - 87,682) 2005 Modelled IHME, GBD 2019 (accessed 2022)
74,998 (61,393 - 87,300) 2004 Modelled IHME, GBD 2019 (accessed 2022)
75,112 (62,103 - 87,743) 2003 Modelled IHME, GBD 2019 (accessed 2022)
75,271 (62,215 - 88,179) 2002 Modelled IHME, GBD 2019 (accessed 2022)
75,422 (62,133 - 89,528) 2001 Modelled IHME, GBD 2019 (accessed 2022)
75,510 (61,925 - 90,249) 2000 Modelled IHME, GBD 2019 (accessed 2022)
75,649 (62,216 - 90,290) 1999 Modelled IHME, GBD 2019 (accessed 2022)
75,915 (62,107 - 90,589) 1998 Modelled IHME, GBD 2019 (accessed 2022)
76,206 (62,363 - 90,549) 1997 Modelled IHME, GBD 2019 (accessed 2022)
76,440 (62,516 - 90,717) 1996 Modelled IHME, GBD 2019 (accessed 2022)
76,517 (62,391 - 90,930) 1995 Modelled IHME, GBD 2019 (accessed 2022)
76,533 (62,532 - 90,203) 1994 Modelled IHME, GBD 2019 (accessed 2022)
76,578 (62,567 - 89,883) 1993 Modelled IHME, GBD 2019 (accessed 2022)
76,631 (62,457 - 89,958) 1992 Modelled IHME, GBD 2019 (accessed 2022)
76,687 (62,465 - 90,376) 1991 Modelled IHME, GBD 2019 (accessed 2022)
76,704 (62,069 - 90,774) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.87 (1.39 - 2.44) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.51 (2.56 - 4.65) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (2.59 - 4.73) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (2.59 - 4.76) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.55 (2.58 - 4.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.54 - 4.68) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.48 (2.52 - 4.62) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.36 (2.45 - 4.45) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.44 (2.52 - 4.56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.33 (2.45 - 4.39) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.28 (2.44 - 4.33) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.28 (2.43 - 4.34) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.37 (2.51 - 4.44) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.29 (2.42 - 4.34) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.44 (2.56 - 4.52) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.38 (2.53 - 4.45) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.32 (2.48 - 4.34) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.17 (2.36 - 4.15) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.25 - 3.96) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.12 - 3.75) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.02 - 3.64) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (1.91 - 3.43) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (1.80 - 3.22) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.71 - 3.03) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.52 - 2.68) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.17 (1.60 - 2.84) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.48 - 2.63) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.45 - 2.53) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.41 - 2.46) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (1.40 - 2.45) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.39 - 2.44) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
503 2016 Modelled WHO
273 (199 - 361) 1990 Modelled IHME, GBD 2019 (accessed 2022)
278 (202 - 368) 1991 Modelled IHME, GBD 2019 (accessed 2022)
280 (203 - 372) 1992 Modelled IHME, GBD 2019 (accessed 2022)
279 (203 - 371) 1993 Modelled IHME, GBD 2019 (accessed 2022)
276 (200 - 369) 1994 Modelled IHME, GBD 2019 (accessed 2022)
275 (199 - 365) 1995 Modelled IHME, GBD 2019 (accessed 2022)
273 (199 - 361) 1996 Modelled IHME, GBD 2019 (accessed 2022)
267 (195 - 353) 1997 Modelled IHME, GBD 2019 (accessed 2022)
265 (195 - 350) 1998 Modelled IHME, GBD 2019 (accessed 2022)
262 (194 - 347) 1999 Modelled IHME, GBD 2019 (accessed 2022)
263 (195 - 348) 2000 Modelled IHME, GBD 2019 (accessed 2022)
273 (203 - 359) 2002 Modelled IHME, GBD 2019 (accessed 2022)
265 (195 - 350) 2001 Modelled IHME, GBD 2019 (accessed 2022)
280 (208 - 368) 2003 Modelled IHME, GBD 2019 (accessed 2022)
277 (207 - 364) 2004 Modelled IHME, GBD 2019 (accessed 2022)
252 (187 - 329) 2007 Modelled IHME, GBD 2019 (accessed 2022)
274 (205 - 358) 2005 Modelled IHME, GBD 2019 (accessed 2022)
262 (196 - 343) 2006 Modelled IHME, GBD 2019 (accessed 2022)
237 (177 - 313) 2008 Modelled IHME, GBD 2019 (accessed 2022)
229 (168 - 304) 2009 Modelled IHME, GBD 2019 (accessed 2022)
217 (160 - 287) 2010 Modelled IHME, GBD 2019 (accessed 2022)
205 (152 - 270) 2011 Modelled IHME, GBD 2019 (accessed 2022)
195 (145 - 256) 2012 Modelled IHME, GBD 2019 (accessed 2022)
184 (136 - 242) 2013 Modelled IHME, GBD 2019 (accessed 2022)
176 (131 - 230) 2014 Modelled IHME, GBD 2019 (accessed 2022)
169 (126 - 221) 2016 Modelled IHME, GBD 2019 (accessed 2022)
173 (128 - 228) 2015 Modelled IHME, GBD 2019 (accessed 2022)
167 (125 - 216) 2017 Modelled IHME, GBD 2019 (accessed 2022)
166 (124 - 217) 2018 Modelled IHME, GBD 2019 (accessed 2022)
167 (124 - 218) 2019 Modelled IHME, GBD 2019 (accessed 2022)
167 (124 - 218) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 10) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7 (4 - 10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
85 2019 Survey/reported WHO/UNICEF
85 2020 Survey/reported WHO/UNICEF
85 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
321 (244 - 468) 2015 Survey/reported EMCDDA, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
50 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HBV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.2 (0.10 - 0.40) 2015 Modelled Blach et al, 2017
0.99 (0.81 - 1.20) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.19) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.79 - 1.19) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.19) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.19) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.81 - 1.19) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.18) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.17) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.16) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.16) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.16) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.15) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.80 - 1.15) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.80 - 1.15) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.80 - 1.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.79 - 1.14) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.79 - 1.15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.79 - 1.16) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.78 - 1.16) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.76 - 1.13) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
59.91 2012 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
48.47 2011 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
47.53 2010 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
54.71 2009 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
47.14 2008 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
47.84 2007 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
54 2006 Survey/reported EMCDDA; GÖG/ÖBIG (unpublished data)
38 2016 Survey/reported EMCDDA
26.8 2015 Survey/reported EMCDDA
51.3 2014 Survey/reported EMCDDA
31.3 2013 Survey/reported EMCDDA
44.3 2012 Survey/reported EMCDDA
34.18 2011 Survey/reported EMCDDA
43.42 2010 Survey/reported EMCDDA
44.74 2009 Survey/reported EMCDDA
52.63 2008 Survey/reported EMCDDA
40 2007 Survey/reported EMCDDA
31.9 2006 Survey/reported EMCDDA
48.03 2005 Survey/reported EMCDDA
38.53 2004 Survey/reported EMCDDA
41.54 2003 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.14 (0.04 - 0.20) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.5 (0.10 - 0.70) 2014 Survey/reported Gower et al, 2014
0.5 2019 Modelled Jin et al. 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
31.3 (18.70 - 46.30) 2013 Survey/reported EMCDDA
60.9 (54.80 - 67) 2012 Modelled Degenhardt L et al, 2017
34 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
21,000 (6,000 - 30,000) 2015 Modelled Blach et al, 2017
69,539 (57,295 - 84,571) 1990 Modelled IHME, GBD 2019 (accessed 2022)
69,933 (57,938 - 84,809) 1991 Modelled IHME, GBD 2019 (accessed 2022)
70,334 (58,409 - 84,724) 1992 Modelled IHME, GBD 2019 (accessed 2022)
70,702 (58,535 - 84,770) 1993 Modelled IHME, GBD 2019 (accessed 2022)
71,106 (59,149 - 85,079) 1994 Modelled IHME, GBD 2019 (accessed 2022)
71,595 (59,366 - 85,521) 1995 Modelled IHME, GBD 2019 (accessed 2022)
71,987 (59,737 - 86,012) 1996 Modelled IHME, GBD 2019 (accessed 2022)
72,364 (60,045 - 86,391) 1997 Modelled IHME, GBD 2019 (accessed 2022)
72,681 (60,116 - 87,150) 1998 Modelled IHME, GBD 2019 (accessed 2022)
73,026 (60,158 - 87,804) 1999 Modelled IHME, GBD 2019 (accessed 2022)
73,481 (60,257 - 88,525) 2000 Modelled IHME, GBD 2019 (accessed 2022)
73,933 (60,880 - 88,962) 2001 Modelled IHME, GBD 2019 (accessed 2022)
74,484 (61,500 - 89,027) 2002 Modelled IHME, GBD 2019 (accessed 2022)
75,019 (61,593 - 89,919) 2003 Modelled IHME, GBD 2019 (accessed 2022)
75,601 (61,957 - 90,993) 2004 Modelled IHME, GBD 2019 (accessed 2022)
76,213 (62,276 - 91,509) 2005 Modelled IHME, GBD 2019 (accessed 2022)
76,638 (62,823 - 92,147) 2006 Modelled IHME, GBD 2019 (accessed 2022)
76,996 (63,449 - 93,171) 2007 Modelled IHME, GBD 2019 (accessed 2022)
77,240 (63,802 - 94,056) 2008 Modelled IHME, GBD 2019 (accessed 2022)
77,469 (64,151 - 94,567) 2009 Modelled IHME, GBD 2019 (accessed 2022)
77,772 (64,423 - 95,507) 2010 Modelled IHME, GBD 2019 (accessed 2022)
77,985 (64,541 - 95,626) 2011 Modelled IHME, GBD 2019 (accessed 2022)
78,184 (64,736 - 95,887) 2012 Modelled IHME, GBD 2019 (accessed 2022)
78,395 (64,590 - 96,513) 2013 Modelled IHME, GBD 2019 (accessed 2022)
78,765 (64,646 - 96,898) 2014 Modelled IHME, GBD 2019 (accessed 2022)
79,341 (64,726 - 97,813) 2015 Modelled IHME, GBD 2019 (accessed 2022)
80,359 (66,224 - 98,189) 2016 Modelled IHME, GBD 2019 (accessed 2022)
81,515 (66,956 - 99,345) 2017 Modelled IHME, GBD 2019 (accessed 2022)
82,512 (67,998 - 99,995) 2018 Modelled IHME, GBD 2019 (accessed 2022)
82,746 (67,850 - 100,439) 2019 Modelled IHME, GBD 2019 (accessed 2020)
83,668 (68,756 - 101,367) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
2,800 (780 - 4,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.25 (4.86 - 7.74) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.31 (4.92 - 8.19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.4 (4.99 - 8.26) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.39 (4.99 - 8.20) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.33 (4.94 - 8.16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (4.89 - 8.10) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (4.89 - 8.08) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.25 (4.89 - 8) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.18 (4.86 - 7.90) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.15 (4.84 - 7.79) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.19 (4.88 - 7.83) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.13 (4.85 - 7.72) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (4.97 - 7.89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.49 (5.14 - 8.20) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.66 (5.29 - 8.44) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (5.28 - 8.43) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.49 (5.18 - 8.12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.49 (5.18 - 8.14) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.6 (5.25 - 8.33) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.48 (5.17 - 8.12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.65 (5.34 - 8.34) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.67 (5.34 - 8.33) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.65 (5.33 - 8.31) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.74 (5.38 - 8.39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6.73 (5.34 - 8.35) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6.66 (5.29 - 8.29) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (5.26 - 8.27) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6.44 (5.09 - 7.97) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6.35 (5.02 - 7.85) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (4.91 - 7.76) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6.25 (4.86 - 7.74) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
588 2016 Modelled WHO
558 (433 - 690) 2019 Modelled IHME, GBD 2019 (accessed 2022)
558 (433 - 690) 2019 Modelled IHME, GBD 2019 (accessed 2020)
555 (435 - 687) 2018 Modelled IHME, GBD 2019 (accessed 2022)
559 (442 - 691) 2017 Modelled IHME, GBD 2019 (accessed 2022)
563 (445 - 696) 2016 Modelled IHME, GBD 2019 (accessed 2022)
575 (455 - 716) 2015 Modelled IHME, GBD 2019 (accessed 2022)
571 (454 - 711) 2014 Modelled IHME, GBD 2019 (accessed 2022)
572 (455 - 710) 2013 Modelled IHME, GBD 2019 (accessed 2022)
569 (454 - 708) 2012 Modelled IHME, GBD 2019 (accessed 2022)
559 (448 - 698) 2011 Modelled IHME, GBD 2019 (accessed 2022)
559 (447 - 697) 2010 Modelled IHME, GBD 2019 (accessed 2022)
555 (446 - 696) 2009 Modelled IHME, GBD 2019 (accessed 2022)
540 (431 - 676) 2008 Modelled IHME, GBD 2019 (accessed 2022)
539 (430 - 674) 2007 Modelled IHME, GBD 2019 (accessed 2022)
537 (429 - 674) 2006 Modelled IHME, GBD 2019 (accessed 2022)
543 (433 - 686) 2005 Modelled IHME, GBD 2019 (accessed 2022)
543 (432 - 690) 2004 Modelled IHME, GBD 2019 (accessed 2022)
542 (431 - 687) 2003 Modelled IHME, GBD 2019 (accessed 2022)
525 (416 - 663) 2002 Modelled IHME, GBD 2019 (accessed 2022)
504 (400 - 635) 2001 Modelled IHME, GBD 2019 (accessed 2022)
496 (392 - 628) 2000 Modelled IHME, GBD 2019 (accessed 2022)
490 (388 - 617) 1999 Modelled IHME, GBD 2019 (accessed 2022)
490 (386 - 620) 1998 Modelled IHME, GBD 2019 (accessed 2022)
491 (386 - 627) 1997 Modelled IHME, GBD 2019 (accessed 2022)
495 (387 - 634) 1996 Modelled IHME, GBD 2019 (accessed 2022)
495 (386 - 638) 1995 Modelled IHME, GBD 2019 (accessed 2022)
494 (385 - 638) 1994 Modelled IHME, GBD 2019 (accessed 2022)
497 (388 - 640) 1993 Modelled IHME, GBD 2019 (accessed 2022)
500 (390 - 642) 1992 Modelled IHME, GBD 2019 (accessed 2022)
499 (389 - 644) 1991 Modelled IHME, GBD 2019 (accessed 2022)
490 (382 - 636) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
15 (11 - 19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 1991 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 1992 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 1994 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 1995 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 1993 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 1996 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 25) 1997 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 25) 1998 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 27) 1999 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 28) 2000 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 32) 2002 Modelled IHME, GBD 2019 (accessed 2022)
26 (20 - 34) 2003 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 36) 2004 Modelled IHME, GBD 2019 (accessed 2022)
30 (22 - 38) 2006 Modelled IHME, GBD 2019 (accessed 2022)
29 (21 - 37) 2005 Modelled IHME, GBD 2019 (accessed 2022)
30 (22 - 38) 2007 Modelled IHME, GBD 2019 (accessed 2022)
30 (22 - 39) 2008 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 40) 2009 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 41) 2010 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 41) 2011 Modelled IHME, GBD 2019 (accessed 2022)
32 (24 - 42) 2012 Modelled IHME, GBD 2019 (accessed 2022)
33 (24 - 43) 2013 Modelled IHME, GBD 2019 (accessed 2022)
33 (24 - 43) 2014 Modelled IHME, GBD 2019 (accessed 2022)
32 (24 - 42) 2015 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 42) 2016 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 43) 2017 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 42) 2018 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 42) 2019 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 42) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
321 (244 - 468) 2015 Survey/reported EMCDDA, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
50 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HBV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.76 (%)
2019
(0.61 - 0.91(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
0.93 (%)
2019
(0.76 - 1.13(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV (anti-HCV)
0.5 (%)
2014
(0.1 - 0.7(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
167
2019
(124 - 218)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
558
2019
(433 - 690)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.16 (%)
2020, latest modelled
(0.10 - 0.23(%))
WHO

Prevalence PWID

HCV
34 (%)
2017, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
321
2015
(244 - 468)
EMCDDA, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Programs